Towards achieving this goal, we identified an unexpected role for activation of cofactor of BRCA1 (COBRA1), a protein traditionally known to be involved in transcription pausing as yet another mechanism potentially contributing to progression to aggressive prostate cancer. The gene discussed is NELFB; the disease is prostate carcinoma.